Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR
Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved..
RATIONALE AND OBJECTIVES: Post-TAVR persistent pulmonary hypertension (PH) is a better predictor of poor outcome than pre-TAVR PH. In this longitudinal study we sought to evaluate whether pulmonary artery (distensibility (DPA) measured on preprocedural ECG-gated CTA is associated with persistent-PH and 2-year mortality after TAVR.
MATERIALS AND METHODS: Three hundred and thirty-six patients undergoing TAVR between July 2012 and March 2016 were retrospectively included and followed for all-cause mortality until November 2017. All patients underwent retrospectively ECG-gated CTA prior to TAVR. Main pulmonary artery (MPA) area was measured in systole and in diastole. DPA was calculated as: [(area-MPAmax-area-MPAmin)/area-MPAmax]%. ROC analysis was performed to assess the AUC for persistent-PH. Youden Index was used to determine the optimal threshold of DPA for persistent-PH. Two groups were compared based on a DPA threshold of 8% (specificity of 70% for persistent-PH). Kaplan-Meier, Cox proportional-hazard, and logistic regression analyses were performed. The primary clinical endpoint was defined as persistent-PH post-TAVR. The secondary endpoint was defined as all-cause mortality 2 years after TAVR.
RESULTS: Median follow-up time was 413 (interquartiles 339-757) days. A total of 183 (54%) had persistent-PH and 68 (20%) patients died within 2-years after TAVR. Patients with DPA<8% had significantly more persistent-PH (67% vs 47%, p<0.001) and 2-year deaths (28% vs 15%, p=0.006), compared to patients with DPA>8%. Adjusted multivariable regression analyses showed that DPA<8% was independently associated with persistent-PH (OR 2.10 [95%-CI 1.3-4.5], p=0.007) and 2-year mortality (HR 2.91 [95%-CI 1.5-5.8], p=0.002). Kaplan-Meier analysis showed that 2-year mortality of patients with DPA<8% was significantly higher compared to patients with DPA≥8% (mortality 28% vs 15%; log-rank p=0.003).
CONCLUSION: DPA on preprocedural CTA is independently associated with persistent-PH and two-year mortality in patients who undergo TAVR.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Academic radiology - 30(2023), 12 vom: 16. Dez., Seite 2825-2833 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Turner, Valery [VerfasserIn] |
---|
Links: |
---|
Themen: |
Computed tomography angiography |
---|
Anmerkungen: |
Date Completed 01.12.2023 Date Revised 10.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.acra.2023.03.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356503321 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM356503321 | ||
003 | DE-627 | ||
005 | 20240310231841.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.acra.2023.03.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n1322.xml |
035 | |a (DE-627)NLM356503321 | ||
035 | |a (NLM)37147161 | ||
035 | |a (PII)S1076-6332(23)00126-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Turner, Valery |e verfasserin |4 aut | |
245 | 1 | 0 | |a Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.12.2023 | ||
500 | |a Date Revised 10.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved. | ||
520 | |a RATIONALE AND OBJECTIVES: Post-TAVR persistent pulmonary hypertension (PH) is a better predictor of poor outcome than pre-TAVR PH. In this longitudinal study we sought to evaluate whether pulmonary artery (distensibility (DPA) measured on preprocedural ECG-gated CTA is associated with persistent-PH and 2-year mortality after TAVR | ||
520 | |a MATERIALS AND METHODS: Three hundred and thirty-six patients undergoing TAVR between July 2012 and March 2016 were retrospectively included and followed for all-cause mortality until November 2017. All patients underwent retrospectively ECG-gated CTA prior to TAVR. Main pulmonary artery (MPA) area was measured in systole and in diastole. DPA was calculated as: [(area-MPAmax-area-MPAmin)/area-MPAmax]%. ROC analysis was performed to assess the AUC for persistent-PH. Youden Index was used to determine the optimal threshold of DPA for persistent-PH. Two groups were compared based on a DPA threshold of 8% (specificity of 70% for persistent-PH). Kaplan-Meier, Cox proportional-hazard, and logistic regression analyses were performed. The primary clinical endpoint was defined as persistent-PH post-TAVR. The secondary endpoint was defined as all-cause mortality 2 years after TAVR | ||
520 | |a RESULTS: Median follow-up time was 413 (interquartiles 339-757) days. A total of 183 (54%) had persistent-PH and 68 (20%) patients died within 2-years after TAVR. Patients with DPA<8% had significantly more persistent-PH (67% vs 47%, p<0.001) and 2-year deaths (28% vs 15%, p=0.006), compared to patients with DPA>8%. Adjusted multivariable regression analyses showed that DPA<8% was independently associated with persistent-PH (OR 2.10 [95%-CI 1.3-4.5], p=0.007) and 2-year mortality (HR 2.91 [95%-CI 1.5-5.8], p=0.002). Kaplan-Meier analysis showed that 2-year mortality of patients with DPA<8% was significantly higher compared to patients with DPA≥8% (mortality 28% vs 15%; log-rank p=0.003) | ||
520 | |a CONCLUSION: DPA on preprocedural CTA is independently associated with persistent-PH and two-year mortality in patients who undergo TAVR | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Computed tomography angiography | |
650 | 4 | |a Pulmonary artery | |
650 | 4 | |a Pulmonary hypertension | |
650 | 4 | |a Transcatheter aortic valve replacement | |
700 | 1 | |a Maret, Eva |e verfasserin |4 aut | |
700 | 1 | |a Kim, Juyong B |e verfasserin |4 aut | |
700 | 1 | |a Codari, Marina |e verfasserin |4 aut | |
700 | 1 | |a Hinostroza, Virginia |e verfasserin |4 aut | |
700 | 1 | |a Mastrodicasa, Domenico |e verfasserin |4 aut | |
700 | 1 | |a Watkins, A Claire |e verfasserin |4 aut | |
700 | 1 | |a Fearon, William F |e verfasserin |4 aut | |
700 | 1 | |a Fischbein, Michael P |e verfasserin |4 aut | |
700 | 1 | |a Haddad, Francois |e verfasserin |4 aut | |
700 | 1 | |a Willemink, Martin J |e verfasserin |4 aut | |
700 | 1 | |a Fleischmann, Dominik |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Academic radiology |d 1995 |g 30(2023), 12 vom: 16. Dez., Seite 2825-2833 |w (DE-627)NLM087676818 |x 1878-4046 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2023 |g number:12 |g day:16 |g month:12 |g pages:2825-2833 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.acra.2023.03.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2023 |e 12 |b 16 |c 12 |h 2825-2833 |